Literature DB >> 21595676

Successful treatment of argyria using a low-fluence Q-switched 1064-nm Nd:YAG laser.

Tae Young Han1, Hee Sun Chang, Hyun Kyung Lee, Sook-Ja Son.   

Abstract

BACKGROUND: Argyria is a rare skin disease caused by cutaneous deposits of silver granules as a result of exposure to silver substrates or ingestion of silver salt. This pigmentation change causes cosmetic problems, and there was previously no recognized effective treatments for argyria.
OBJECTIVE: To evaluate the treatment effect of a low-fluence Q-switched 1064-nm Nd:YAG laser on argyria. SUBJECTS AND METHODS: Case report of a 49-year-old with a history of ingestion of a colloidal silver solution daily for approximately one year as a traditional remedy.
RESULTS: After seven sessions of treatment, the patient's skin color returned to normal.
CONCLUSION: A low-fluence Q-switched 1064-nm Nd:YAG laser provided safe and effective treatment for the skin discoloration associated with argyria.
© 2011 The International Society of Dermatology.

Entities:  

Mesh:

Year:  2011        PMID: 21595676     DOI: 10.1111/j.1365-4632.2010.04796.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  4 in total

1.  Quantitative near infrared spectroscopic analysis of Q-Switched Nd:YAG treatment of generalized argyria.

Authors:  Rolf B Saager; Khaled M Hassan; Clement Kondru; Anthony J Durkin; Kristen M Kelly
Journal:  Lasers Surg Med       Date:  2013-01-15       Impact factor: 4.025

2.  Argyria -- case report.

Authors:  André Lencastre; Maria Lobo; Alexandre João
Journal:  An Bras Dermatol       Date:  2013 May-Jun       Impact factor: 1.896

3.  Side-by-side Comparison of a Picosecond 755-nm Alexandrite Laser and a Quality-switched 1064-nm Neodymium-doped Yttrium Aluminum Garnet Laser in the Treatment of Argyria.

Authors:  Emma Weiss; Kaitlyn L Streight; Christopher B Rizk; Ramsey Markus
Journal:  Cureus       Date:  2019-07-23

Review 4.  Clinical and Forensic Aspects of the Different Subtypes of Argyria.

Authors:  Luís Mota; Ricardo Jorge Dinis-Oliveira
Journal:  J Clin Med       Date:  2021-05-13       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.